| AA | amino acid residue |
| CRAB | carbapenem-resistant Acinetobacter baumannii |
| DMF | N,N-dimethylformamide |
| LAR-B | Lariocidin B |
| MccJ25 | Microcin J25 |
| MDR | Multi-drug-resistant |
| MHB | cation-adjusted Mueller–Hinton broth |
| MIC | minimum inhibitory concentration |
| MRSA | methicillin-resistant Staphylococcus aureus |
| NMP | N-methylpyrrolidone |
| PTM | post-translational modification |
| RiPP | post-translationally modified peptide |
| RPMI-1640 | nutrient-limited medium |
| RRE | RiPP precursor recognition element |
| SPPS | solid-phase peptide synthesis |
| SPS | solid-phase synthesis |
| STEC | Shiga toxin-producing E. coli |
| WHO BPPL | WHO Bacterial Priority Pathogens List |
| VA | vancomycin |
| VRE | vancomycin-resistant enterococci |
| VRSA | vancomycin-resistant Staphylococcus aureus |